Dabigatran etexilate capsules (Pradaxa) dosage and usage

Dabigatran etexilate capsules (Pradaxa) is a direct thrombin inhibitor used to prevent and treat thrombosis-related diseases, including non-valvular atrial fibrillation, deep vein thrombosis and pulmonary embolism. When using dabigatran etexilate capsules, the appropriate dosage needs to be determined based on the patient's specific conditions and disease indications. Below are detailed instructions on how to take dabigatran etexilate capsules and dosage for different indications.

How to take:

1.Oral administration: Dabigatran etexilate capsule is an oral drug and should be swallowed whole. The capsule should not be chewed or opened. Can be taken with or without food, depending on individual tolerance.

2.Irregular monitoring: Unlike traditional anticoagulant drugs (such as warfarin), dabigatran etexilate capsules do not require regular monitoring of coagulation time. This reduces the patient's medication burden, but it is still necessary to regularly review indicators such as liver function and kidney function to ensure that the patient's physical condition is suitable for continued use.

3.Use strictly according to the doctor's instructions: Patients must use dabigatran etexilate capsules in strict accordance with the doctor's recommendations and prescriptions. They are not allowed to adjust the dosage or stop using it on their own, so as not to affect the efficacy and safety of the drug.

Dosage for different indications:

1.Stroke prevention in non-valvular atrial fibrillation:

110 mg dose: For some patients who are older, have impaired renal function, or need to reduce the risk of bleeding, a dose of 110 mg twice daily is often recommended.

150 mg dose: In some moderate-risk patients, a dose of 150 mg twice daily is often recommended. This dose provides a more potent anticoagulant effect than the dose of 110 mg.

2.Treatment of deep vein thrombosis and pulmonary embolism:

150 mg dose: In the treatment of deep vein thrombosis and pulmonary embolism, a dose of 150 mg twice daily is often recommended to more rapidly reduce or eliminate existing blood clots.

3.Postoperative anticoagulation:

150 mg dose: For some patients who require surgery, especially those undergoing high-risk surgeries such as joint replacement surgery, a dose of 150 mg is usually used before and after surgery to prevent the formation of postoperative thrombosis.

Different indications and individual patient differences may affect dosage selection. Therefore, patients should receive evaluation from a doctor before using dabigatran etexilate capsules and undergo regular monitoring according to medical advice. The doctor will develop the most appropriate treatment plan based on the patient's age, kidney function, overall health and other factors. Patients should fully understand their risks and treatment options, and work closely with their doctors to ensure the best treatment results.

Dabigatran etexilate capsules have been launched in China and have been included in medical insurance. Patients can purchase them domestically. Please consult the local hospital pharmacy for specific prices. The main foreign drug is the original drug of dabigatran etexilate capsules. The cheaper one is the Turkish version of the original drug from Germany. The price of 110mg*60 capsules is about three to four hundred, and the ingredients and efficacy are consistent with the original drug on the domestic market.